Description: The last three decades have witnessed an important rise in number of people with diabetes in Asia, especially Type 2 Diabetes. Like no other common condition, numerous innovations are currently entering the healthcare system that will soon have a significant impact on management of the condition. This presentation explores the role played by sensors/wearables, artificial intelligence, new drugs and diabetes apps. We assess the realistic potential of such advancements and give an outlook on medium-term pricing and product development.

Description: Stale portfolio got your sales down? In this session, you'll learn about the latest and greatest in product development trends and innovations which you can use to refresh and revitalize your products. At the conclusion of this session, attendees will have a better understanding on market trends in product development as well as leading innovations.

Description: This session provides an overview of industry approaches to valuing the liabilities of nontraditional health products such as specific and employer stop loss, provider excess and critical illness. From the Record of the Society of Actuaries, Volume 29, No. 2, Session 117

Description: Panelists address current issues of critical illness products including underwriting, state filing, distribution and marketing. From the Record of the Society of Actuaries, Volume 28, No. 1, Session 33

Description: This session explores the aspects and the issues of offering a critical illness product in various markets, including individual, group, worksite and direct response. From the Record of the Society of Actuaries, Volume 28, No. 3, Session 7

Description: This session provides an overview of industry approaches to valuing the liabilities of nontraditional health products. Liabilities for losses that have been incurred but not reported and for losses that have been reported but not paid are examined. Includes a discussion on employer specific stop-loss, provider excess loss, critical illness and cancer insurance. From the Record of the Society of Actuaries, Volume 28, No. 2, Session 133

Description: The panelists in this session discuss the current state of the CI market in the United States and Canada as well as an overview of seveal other countries. Specific topics to be addressed include product features, marketing and producer issues. From the Record of the Society of Actuaries, Volume 29, No. 2, Session 24

Description: Panelists examine various types of critical illness plans, its success in Canada and other markets, and the challenges and opportunities for the U.S. market.

Description: Critical illness policies pay a large lump sum based upon diagnosis of conditions such as heart attack, stroke, life-threatening cancer, kidney failure, etc. From Record of Society of Actuaries, Volume 26, No. 1, session 119PD of the Las Vegas Spring Meeting.

Description: This panel discussion addresses Critical Illness product design, marketing, trends and lessons learned from other countries. From the Record of the Society of Actuaries, Volume 27, No. 2, Session 20